Sarcopenia refers to the loss of skeletal muscle mass and strength associated with aging. With the rise in geriatric population globally, sarcopenia has emerged as a major health concern. Treatment of sarcopenia involves nutritional supplementation, vitamin D, protein intake, weight training and medications. Proper treatment can help improve muscle strength and physical performance of elderly. Some commonly used supplements for sarcopenia treatment include vitamin D, omega-3 fatty acids, amino acids like leucine and protein supplements.
The Global Sarcopenia Treatment Market is estimated to be valued at US$ 28.19 Bn in 2024 and is expected to exhibit a CAGR of 6.9% over the forecast period 2024 To 2031.
Key Takeaways
Key players operating in the Sarcopenia Treatment are Abbott Laboratories, Agilent Technologies, Affymetrix Inc., Beckman Coulter, Inc., Illumina Incorporated, Life Technologies Corporation, Randox Laboratories Ltd., Surfix B.V, GE Healthcare, F. Hoffmann-La Roche Ltd, and AYOXXA Biosystems GmbH.
The rising incidence of chronic diseases coupled with increasing healthcare spending offers immense opportunities for players in the sarcopenia treatment market. The development of nutritional supplements with disease-modifying capabilities will further boost the market growth.
With increasing life expectancy across regions, major players are focusing on expanding their product portfolio and global footprint especially in Asia Pacific and Latin America.
Market Drivers
The rapid growth in Sarcopenia Treatment Market Trends. geriatric population worldwide is the major driver for sarcopenia treatment market. As per WHO estimates, the population aged 60 years and above is projected to reach 2.1 billion by 2050 from 962 million in 2017. Also, sedentary lifestyle and lack of physical activity associated with aging further aggravates the condition. Favorable government policies and initiatives to improve age related healthcare facilities will augment the adoption of sarcopenia treatment solutions over forecast period.
PEST Analysis
Political: The regulation relating to pharmaceutical and biomedical industry is quite strict. Sarcopenia Treatment Market Companies stringent approval process from regulatory bodies like FDA delays the entry of new products in the market.
Economic: Ageing population and rise in chronic illnesses worldwide is driving the demand for sarcopenia treatment. However, higher treatment cost can restrain the market growth to some extent.
Social: Increased health awareness and focus on active ageing is encouraging people to look for treatment options for muscle loss and weakness associated with ageing. Lifestyle changes can partially help in preventing or delaying the onset of sarcopenia.
Technological: Advancements in fields of proteomics, genomic and molecular biomarkers are facilitating the development of novel diagnostic tools and drugs for accurate identification and effective treatment of sarcopenia. Research in areas of nutrition, physiotherapy and gene therapy also offers new prospects.
North America currently dominates the sarcopenia treatment market in terms of revenue due to rapidly ageing population, high healthcare spending and concentration of key players in the region. However, Asia Pacific is identified as the most promising emerging market and will exhibit the fastest growth during the forecast period owing to rising geriatric population, growing healthcare infrastructure and improving access to treatment in major countries like China and India.
Europe holds the second position in sarcopenia treatment market supported by higher per capita income, availability of specialized healthcare services and increasing healthcare expenditure dedicated for elderly care. The rate of increase in elderly population makes Japan an attractive market in Asia pacific region.
Explore More Related Article On- Lactulose Market
Unlock More Insights—Explore the Report in the Language You Prefer
About Author:
Vaagisha brings over three years of expertise as a content editor in the market research domain. Originally a creative writer, she discovered her passion for editing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups.
(LinkedIn: https://www.linkedin.com/in/vaagisha-singh-8080b91)
Comments
0 comment